Baloxavir marboxil

Chemical formula: C₂₇H₂₃F₂N₃O₇S  Molecular mass: 571.55 g/mol 

Therapeutic indications

Baloxavir marboxil is indicated for:

Influenza

Population group: only infants (40 days - 1 year old) , children (1 year - 12 years old) , adolescents (12 years - 18 years old) , adults (18 years old or older)

Baloxavir marboxil is indicated for the treatment of uncomplicated influenza in patients aged 3 weeks and above.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Post-exposure prophylaxis of influenza

Population group: only infants (40 days - 1 year old) , children (1 year - 12 years old) , adolescents (12 years - 18 years old) , adults (18 years old or older)

Baloxavir marboxil is indicated for post-exposure prophylaxis of influenza in individuals aged 3 weeks and above.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Baloxavir marboxil is contraindicated in the following cases:

Lactation

Lactation

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.